Regentis Biomaterials RGNT Income Statement (2024-2026)

NYSE RGNT
$1.90 +0.05 (+2.70%)
As of: Sep 30, 2026 · 2:27 PM EDT
Reported Financials

Regentis Biomaterials Quarterly Income Statement

Periods 3 quarters
Latest Jun 2026

Regentis Biomaterials income statement data for the quarter ended Jun 2026. This income statement covers 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2024 Dec2025 Jun2026
Additional items
Shares Outstanding 2.77M0.57M0.57M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 2.77M0.57M0.57M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 2.77M0.57M

Regentis Biomaterials Income Statement API

Pull Regentis Biomaterials's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY